Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Chest
|
January 10, 2022
Rebuttal From Dr Downey
Damian G Downey
Chest
|
January 10, 2022
POINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? Yes
Damian G Downey
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 2, 2019
Letter to the editor: Challenges and opportunities in the development of future CFTR modulator options for people with CF
Damian G Downey, Jennifer Taylor-Cousar
Current Opinion in Pulmonary Medicine
|
August 21, 2018
Theratyping in cystic fibrosis
Kathryn J Crawford, Damian G Downey
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
CFTR Modulators and Rare Variants-Leaping from Laboratory Cells to Real World Effectiveness?
Nicholas J Simmonds, Damian G Downey
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 25, 2019
Tackling bias in clinical trials
Silke van Koningsbruggen-Rietschel, Damian G Downey
International Journal of Clinical Pharmacy
|
December 31, 2015
Pharmacists' perspectives on monitoring adherence to treatment in Cystic Fibrosis
Karen Mooney, Cristín Ryan, Damian G Downey
Expert Review of Respiratory Medicine
|
June 17, 2020
The role of inflammation in cystic fibrosis pulmonary exacerbations
Claire J Houston, Clifford C Taggart, Damian G Downey
International Journal of Clinical Pharmacy
|
July 31, 2016
A change in behaviour: getting the balance right for research and policy
Maureen O'Sullivan, Cristín Ryan, Damian G Downey, et al.
International Journal of Molecular Sciences
|
April 12, 2022
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
Caitlyn Harvey, Sinead Weldon, Stuart Elborn, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Chest
|
January 10, 2022
Rebuttal From Dr Downey
Damian G Downey
Chest
|
January 10, 2022
POINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? Yes
Damian G Downey
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 2, 2019
Letter to the editor: Challenges and opportunities in the development of future CFTR modulator options for people with CF
Damian G Downey, Jennifer Taylor-Cousar
Current Opinion in Pulmonary Medicine
|
August 21, 2018
Theratyping in cystic fibrosis
Kathryn J Crawford, Damian G Downey
American Journal of Respiratory and Critical Care Medicine
|
February 25, 2026
CFTR Modulators and Rare Variants-Leaping from Laboratory Cells to Real World Effectiveness?
Nicholas J Simmonds, Damian G Downey
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 25, 2019
Tackling bias in clinical trials
Silke van Koningsbruggen-Rietschel, Damian G Downey
International Journal of Clinical Pharmacy
|
December 31, 2015
Pharmacists' perspectives on monitoring adherence to treatment in Cystic Fibrosis
Karen Mooney, Cristín Ryan, Damian G Downey
Expert Review of Respiratory Medicine
|
June 17, 2020
The role of inflammation in cystic fibrosis pulmonary exacerbations
Claire J Houston, Clifford C Taggart, Damian G Downey
International Journal of Clinical Pharmacy
|
July 31, 2016
A change in behaviour: getting the balance right for research and policy
Maureen O'Sullivan, Cristín Ryan, Damian G Downey, et al.
International Journal of Molecular Sciences
|
April 12, 2022
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
Caitlyn Harvey, Sinead Weldon, Stuart Elborn, et al.
Page
of 8